IMPACT STATEMENT
Concerns on the long-term efficacy and safety of current treatments for
pediatric AD have propelled the search for therapeutic alternatives,
including postbiotics. This study compares the efficacy and safety of
different postbiotic preparations for treating pediatric AD. This NMA
shows biotherapeutic potential of inanimate Lactobacillus
rhamnosus. Our findings may assist healthcare professionals in making
evidence-based decisions for pediatric AD patients and enrich our
current microbial research focusing on biotics .